← Leaderboards
David M White
University Of Chicago
$1,299,306
Attributed
$1,299,306
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $300K · FY2005–17$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$1,299,306 · 4
By mechanism
R43$737,806 · 2
R21$457,500 · 1
R41$104,000 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Chicago
Same institution · by research overlap
- Irina V Balyasnikova$8,101,877
- Daniel E Johnson$10,482,584
- Jenna Guthmiller$1,932,976
Others in their field
Top investigators on “Ligands”
- John Damon Chodera · Sloan-Kettering Inst Can Research$39,009,297
- Keith W Miller · Massachusetts General Hospital$35,506,092
- Ian A Wilson · Scripps Research Institute, The$35,392,112
- Bryan L Roth · Univ Of North Carolina Chapel Hill$32,442,555
- Edward Franklin Plow · Cleveland Clinic Foundation$32,215,714
- Helen M Berman · Rutgers University New Brunswick$32,076,400
Research focus
LigandsVaccine DevelopmentAntigensResponseBaseAdjuvantAntibody FormationLaboratory MouseToxic EffectReceptor BindingChimeric ProteinsAntigen Presenting CellImmune ResponseAntigen-Presenting CellsGenerationsExposure ToFutureHelper T LymphocyteBioterrorism /Chemical WarfareDendritic CellsCellsBiothreatAdvanced DevelopmentAntibody Receptor
Grant awards (6)
Enhanced NK cell activation via Fc receptor ligand - cytokine combinations$150,000
R43 · FY2017 · CA · contact PI
Rapid Response Vaccines for Botulinum Neurotoxins$287,806
R43 · FY2012 · AI · contact PI
Rapid Response Vaccines for Botulinum Neurotoxins$300,000
R43 · FY2011 · AI · contact PI
Antigen delivery using novel Fc receptor ligands$228,750
R21 · FY2005 · AI
Antigen delivery using novel Fc receptor ligands$228,750
R21 · FY2004 · AI
Vaccine enhancement through antigen targeting$104,000
R41 · FY2004 · AI